Here's Wouldn't Touch Tilray: A Cautious Investor Guide
Tilray’s pivot to CBD and alcohol sparks questions about profitability and risk. This guide cuts through the hype, of...
Compare expense costs of SP 500 vs balanced funds to determine the cheaper option for retirement over time.
24,661 articlesTilray’s pivot to CBD and alcohol sparks questions about profitability and risk. This guide cuts through the hype, of...
A noteworthy fund increased its Celcuity stake by 135,000 shares, signaling potential catalysts and shifting risk. Le...
Investors are increasingly adding blue-chip art to mainstream portfolios to diversify beyond stocks and bonds. Fracti...
Germany faces a policy crossroads: broaden the VAT base to shift the burden from labor to consumption. This article b...
Imagine a world where your phone pays you back for every scroll and tap. This article dives into Mode Mobile, a specu...
Investors are zooming in on InspireMD after its Q1 2026 earnings. This detailed look breaks down the numbers, the pro...
Imagine a beloved sneaker brand reinventing itself with AI and a bold rebrand. This speculative piece explores how su...
When markets swing, investors ask if XRP is the best crypto right now. This guide breaks down what that label means, ...
When a uranium energy stock pops, investors pause to ask what changed and whether the rally can last. This guide brea...
Philip Morris International is steering a bold pivot toward smoke-free products, aiming to drive more than two-thirds...
Desalination facilities in the region are at the center of rising tensions, elevating the mideast’s water supply risk...
Investors debate timing as IREN plans a bold AI expansion after a major capital raise. This guide breaks down the pla...